Coordinated Acquisition of Inhibitory and Activating Receptors and Functional Properties by Developing Human Natural Killer Cells

Overview

Journal Blood

Publisher Elsevier

Specialty Hematology

Date 2006 Aug 12

PMID 16902150

Citations 81

Authors

Bartosz Grzywacz

Nandini Kataria

Magdalena Sikora

Robert A Oostendorp

Elaine A Dzierzak

Bruce R Blazar

Jeffrey S Miller

Michael R Verneris

Affiliations

Soon will be listed here.

Abstract

The stages of human natural killer (NK) cell differentiation are not well established. Culturing CD34(+) progenitors with interleukin 7 (IL-7), IL-15, stem cell factor (SCF), FLT-3L, and murine fetal liver cell line (EL08.1D2), we identified 2 nonoverlapping subsets of differentiating CD56(+) cells based on CD117 and CD94 (CD117(high)CD94(-) and CD117(low/-)CD94(+) cells). Both populations expressed CD161 and NKp44, but differed with respect to NKp30, NKp46, NKG2A, NKG2C, NKG2D, CD8, CD16, and KIR. Only the CD117(low/-) CD94(+) population displayed cytotoxicity and interferon-gamma production. Both populations arose from a single CD34(+)CD38(-) Lin(-) cell and their percentages changed over time in a reciprocal fashion, with CD117(high)CD94(-) cells predominating early and decreasing due to an increase of the CD117(low/-)CD94(+) population. These 2 subsets represent distinct stages of NKcell differentiation, since purified CD117(high) CD94(-) cells give rise to CD117(low/-)CD94(+) cells. The stromal cell line (EL08.1D2) facilitated the transition from CD117(high)CD94(-) to CD117(low/-)CD94(+) via an intermediate phenotype (CD117(low)CD94(low/-)). EL08.1D2 also maintained the mature phenotype, preventing the reversion of CD117(low/-)CD94(+) cells to the intermediate (CD117(low)CD94(low/-)) phenotype. An analogous population of CD56(+)CD117(high)CD94(-) cells was found in cord blood. The identified stages of NK-cell differentiation provide evidence for coordinated acquisition of HLA-specific inhibitory receptors (ie, CD94/NKG2A) and function in developing human NK cells.

Citing Articles

Comprehensive snapshots of natural killer cells functions, signaling, molecular mechanisms and clinical utilization.

Chen S, Zhu H, Jounaidi Y Signal Transduct Target Ther. 2024; 9(1):302.

PMID: 39511139 PMC: 11544004. DOI: 10.1038/s41392-024-02005-w.

Generation of autologous hematopoietic stem cell-derived T lymphocytes for cancer immunotherapy.

Maneechai K, Khopanlert W, Noiperm P, Udomsak P, Viboonjuntra P, Julamanee J Heliyon. 2024; 10(19):e38447.

PMID: 39398019 PMC: 11467635. DOI: 10.1016/j.heliyon.2024.e38447.

Thymic NK-Cells and Their Potential in Cancer Immunotherapy.

Forbes C, Nierkens S, Cornel A Immunotargets Ther. 2024; 13:183-194.

PMID: 38558927 PMC: 10979679. DOI: 10.2147/ITT.S441639.

Unwinding the Role of the CMG Helicase in Inborn Errors of Immunity.

Guilz N, Ahn Y, Seo S, Mace E J Clin Immunol. 2023; 43(5):847-861.

PMID: 36809597 PMC: 10789183. DOI: 10.1007/s10875-023-01437-3.

Altered distribution and function of NK-cell subsets lead to impaired tumor surveillance in JAK2V617F myeloproliferative neoplasms.

Fernandes de Oliveira Costa A, Marani L, Bianco T, Queiroz Arantes A, Aparecida Lopes I, Pereira-Martins D Front Immunol. 2022; 13:768592.

PMID: 36211444 PMC: 9539129. DOI: 10.3389/fimmu.2022.768592.

References

Uhrberg M, Valiante N, Shum B, Shilling H, Corliss B, Tyan D . Human diversity in killer cell inhibitory receptor genes. Immunity. 1998; 7(6):753-63. DOI: 10.1016/s1074-7613(00)80394-5. View

Voss S, Daley J, Ritz J, Robertson M . Participation of the CD94 receptor complex in costimulation of human natural killer cells. J Immunol. 1998; 160(4):1618-26. View

Harada H, Watanabe S, Saijo K, Ishiwata I, Ohno T . A Wilms tumor cell line, HFWT, can greatly stimulate proliferation of CD56+ human natural killer cells and their novel precursors in blood mononuclear cells. Exp Hematol. 2004; 32(7):614-21. DOI: 10.1016/j.exphem.2004.03.011. View

Mingari M, Vitale C, Cantoni C, Bellomo R, Ponte M, Schiavetti F . Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor. Eur J Immunol. 1997; 27(6):1374-80. DOI: 10.1002/eji.1830270612. View

Fehniger T, Shah M, Turner M, VanDeusen J, Whitman S, Cooper M . Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response. J Immunol. 1999; 162(8):4511-20. View

Vitale M, Zimmer J, Castriconi R, Hanau D, Donato L, Bottino C . Analysis of natural killer cells in TAP2-deficient patients: expression of functional triggering receptors and evidence for the existence of inhibitory receptor(s) that prevent lysis of normal autologous cells. Blood. 2002; 99(5):1723-9. DOI: 10.1182/blood.v99.5.1723. View

Addison E, North J, Bakhsh I, Marden C, Haq S, Al-Sarraj S . Ligation of CD8alpha on human natural killer cells prevents activation-induced apoptosis and enhances cytolytic activity. Immunology. 2005; 116(3):354-61. PMC: 1802415. DOI: 10.1111/j.1365-2567.2005.02235.x. View

Kisielow P, Teh H, Bluthmann H, von Boehmer H . Positive selection of antigen-specific T cells in thymus by restricting MHC molecules. Nature. 1988; 335(6192):730-3. DOI: 10.1038/335730a0. View

Cooper M, Fehniger T, Turner S, Chen K, Ghaheri B, Ghayur T . Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset. Blood. 2001; 97(10):3146-51. DOI: 10.1182/blood.v97.10.3146. View

10.

Vitale M, Della Chiesa M, Carlomagno S, Pende D, Arico M, Moretta L . NK-dependent DC maturation is mediated by TNFalpha and IFNgamma released upon engagement of the NKp30 triggering receptor. Blood. 2005; 106(2):566-71. DOI: 10.1182/blood-2004-10-4035. View

11.

Vaz F, Srour E, Almeida-Porada G, Ascensao J . Human thymic stroma supports human natural killer (NK) cell development from immature progenitors. Cell Immunol. 1998; 186(2):133-9. DOI: 10.1006/cimm.1998.1303. View

12.

Paloneva J, Kestila M, Wu J, Salminen A, Bohling T, Ruotsalainen V . Loss-of-function mutations in TYROBP (DAP12) result in a presenile dementia with bone cysts. Nat Genet. 2000; 25(3):357-61. DOI: 10.1038/77153. View

13.

Sivakumar P, Gunturi A, Salcedo M, Schatzle J, Lai W, Kurepa Z . Cutting edge: expression of functional CD94/NKG2A inhibitory receptors on fetal NK1.1+Ly-49- cells: a possible mechanism of tolerance during NK cell development. J Immunol. 1999; 162(12):6976-80. View

14.

Valiante N, Uhrberg M, Shilling H, Arnett K, DAndrea A, Phillips J . Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors. Immunity. 1998; 7(6):739-51. DOI: 10.1016/s1074-7613(00)80393-3. View

15.

Nguyen S, Dhedin N, Vernant J, Kuentz M, Al Jijakli A, Rouas-Freiss N . NK-cell reconstitution after haploidentical hematopoietic stem-cell transplantations: immaturity of NK cells and inhibitory effect of NKG2A override GvL effect. Blood. 2005; 105(10):4135-42. DOI: 10.1182/blood-2004-10-4113. View

16.

Cantoni C, Bottino C, Vitale M, Pessino A, Augugliaro R, Malaspina A . NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamily. J Exp Med. 1999; 189(5):787-96. PMC: 2192947. DOI: 10.1084/jem.189.5.787. View

17.

Lotzova E, Savary C . Human natural killer cell development from bone marrow progenitors: analysis of phenotype, cytotoxicity and growth. Nat Immun. 1993; 12(4-5):209-17. View

18.

Matos M, Schnier G, Beecher M, Ashman L, William D, Caligiuri M . Expression of a functional c-kit receptor on a subset of natural killer cells. J Exp Med. 1993; 178(3):1079-84. PMC: 2191187. DOI: 10.1084/jem.178.3.1079. View

19.

Storms R, Goodell M, Fisher A, Mulligan R, Smith C . Hoechst dye efflux reveals a novel CD7(+)CD34(-) lymphoid progenitor in human umbilical cord blood. Blood. 2000; 96(6):2125-33. View

20.

Loza M, Perussia B . The IL-12 signature: NK cell terminal CD56+high stage and effector functions. J Immunol. 2003; 172(1):88-96. DOI: 10.4049/jimmunol.172.1.88. View